REPORTS

Let’s Pullulate and Expand Your Business

Exocrine Pancreatic Insufficiency Market - Global Professional Analysis and Forecast to 2026

Oct 18, 2019  |  191 PAGES  |  REPORT CODE: CMM216596
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Exocrine Pancreatic Insufficiency market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.5% during the forecast period.

This report presents the market size and development trends by detailing the Exocrine Pancreatic Insufficiency market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Exocrine Pancreatic Insufficiency market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Exocrine Pancreatic Insufficiency industry and will help you to build a panoramic view of the industrial development.

Exocrine Pancreatic Insufficiency Market, By Type:

  • Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye)

  • Phase III Drugs

Exocrine Pancreatic Insufficiency Market, By Application:

  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Sales

  • Others

Some of the leading players are as follows:

  • Digestive Care, Inc.

  • Abbvie Inc.

  • Nordmark Arzneimittel GmbH & Co. KG

  • Janssen Pharmaceuticals Inc.

  • Cilian AG

  • AzurRx BioPharma, Inc.

  • Allergan plc.

  • Anthera Pharmaceuticals Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Exocrine Pancreatic Insufficiency Market: Technology Type Analysis

  • 4.1 Exocrine Pancreatic Insufficiency Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Exocrine Pancreatic Insufficiency Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye)

    • 4.3.2 Phase III Drugs

5 Exocrine Pancreatic Insufficiency Market: Product Analysis

  • 5.1 Exocrine Pancreatic Insufficiency Product Market Share Analysis, 2018 & 2026

  • 5.2 Exocrine Pancreatic Insufficiency Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Exocrine Pancreatic Insufficiency Market: Application Analysis

  • 6.1 Exocrine Pancreatic Insufficiency Application Market Share Analysis, 2018 & 2026

  • 6.2 Exocrine Pancreatic Insufficiency Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital Pharmacy

    • 6.3.2 Retail Pharmacy

    • 6.3.3 Online Sales

    • 6.3.4 Others

7 Exocrine Pancreatic Insufficiency Market: Regional Analysis

  • 7.1 Exocrine Pancreatic Insufficiency Regional Market Share Analysis, 2018 & 2026

  • 7.2 Exocrine Pancreatic Insufficiency Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Digestive Care, Inc.

    • 9.1.1 Digestive Care, Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Abbvie Inc.

    • 9.2.1 Abbvie Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Nordmark Arzneimittel GmbH & Co. KG

    • 9.3.1 Nordmark Arzneimittel GmbH & Co. KG Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Janssen Pharmaceuticals Inc.

    • 9.4.1 Janssen Pharmaceuticals Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Cilian AG

    • 9.5.1 Cilian AG Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 AzurRx BioPharma, Inc.

    • 9.6.1 AzurRx BioPharma, Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Allergan plc.

    • 9.7.1 Allergan plc. Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Anthera Pharmaceuticals Inc.

    • 9.8.1 Anthera Pharmaceuticals Inc. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

 

The List of Tables and Figures (Totals 91 Figures and 143 Tables)

  • Figure Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye) Exocrine Pancreatic Insufficiency market, 2015 - 2026 (USD Million)

  • Figure Phase III Drugs Exocrine Pancreatic Insufficiency market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Online Sales market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Exocrine Pancreatic Insufficiency market, by country, 2015 - 2026 (USD Million)

  • Table North America Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table North America Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table North America Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Canada Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Canada Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Europe Exocrine Pancreatic Insufficiency market, by country, 2015 - 2026 (USD Million)

  • Table Europe Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Europe Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Europe Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Germany Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Germany Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table France Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table France Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Italy Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Italy Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Spain Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Spain Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exocrine Pancreatic Insufficiency market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table China Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table China Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Japan Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Japan Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table India Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table India Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Exocrine Pancreatic Insufficiency market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table MEA Exocrine Pancreatic Insufficiency market, by country, 2015 - 2026 (USD Million)

  • Table MEA Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table MEA Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table MEA Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Exocrine Pancreatic Insufficiency market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Exocrine Pancreatic Insufficiency market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Exocrine Pancreatic Insufficiency market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Digestive Care, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbvie Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nordmark Arzneimittel GmbH & Co. KG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cilian AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AzurRx BioPharma, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan plc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Anthera Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top